Oct. 13 (UPI) — U.S. Air Force’s Air Combat Command has approved Raytheon’s StormBreaker smart weapon for use on the F-15E, Raytheon announced Tuesday.
“StormBreaker delivers an unprecedented capability to pilots in the field,” said Paul Ferraro, vice president of Raytheon’s Air Power business, in a press release. “The weapon gives airmen a significant advantage – the ability to strike maritime or land-based maneuvering targets at range in adverse weather.”
The StormBreaker, which entered operational testing in 2018, is a small diameter bomb that features a multimode seeker to guide the weapon with infrared, millimeter-wave radar and semi-active lasers in addition to or with GPS and inertial system guide.
The Air Force’s fielding decision means F-15E squadrons can now be equipped with the weapon. The Navy and Marines intend to use it on their versions of the F-35 Joint Strike Fighter.
The StormBreaker’s small size means fewer aircraft can address the same number of targets compared to larger weapons, which require multiple jets.
The bomb can also fly more than 40 miles to hit mobile targets.
“The weapon has proven itself in many complex test scenarios, against a variety of targets in extreme environmental conditions, and is now ready to fly,” said Cristy Stagg, StormBreaker program director at Raytheon. “With its multimode seeker and datalink, StormBreaker will make adverse weather irrelevant.”
In February Raytheon was awarded a $15 million increase to a previous contract for StormBreaker technical support.
RapidAI Among the First Stroke Imaging Companies with Software Approved for Medicare New Technology Add-on Payment
Stroke Imaging Makes Significant Stride in Reimbursement. Helps U.S. Hospitals More Easily Adopt the Latest Advancements in Stroke Care
RapidAI, the worldwide leader in advanced imaging for stroke, today announced Rapid LVO is among the first software products to qualify for the New Technology Add-on Payment (NTAP). NTAP is part of the CMS Inpatient Prospective Payment System (IPPS). A significant advancement in stroke care and reimbursement for Medicare patients, the news further fuels the expansion of advanced stroke imaging for those technologies that meet the NTAP requirements, foremost Rapid LVO from RapidAI.
The new NTAP program applies to LVO triage and notification for stroke. Rapid LVO explicitly meets the definition of measuring arterial blood flow in the brain per the issued NTAP code definition. RapidAI offers the most comprehensive stroke imaging platform available. Once an LVO (Large Vessel Occlusion) is identified, Rapid ASPECTS can quantify the severity of the stroke, and Rapid CTP or Rapid MRI can then notify a stroke team if a patient is eligible for thrombectomy.
“Our mission can be simply stated…save lives, save time and save money,” said Don Listwin, CEO of RapidAI. “This exciting new development in Medicare reimbursement may at first seem like just a bookkeeping issue or just a win for RapidAI, the industry leader. However, in truth, this is not a step forward for any one company, but instead an advancement for various software technologies with the end goals of saving more lives and enabling better patient outcomes.”
RapidAI makes the most-widely used stroke imaging software for patient care, research, and clinical trials—helping hospitals around the world save time, money, and lives. Rapid is the only clinically validated platform available and considered by many to be the gold standard for advanced cerebrovascular imaging.
To learn more visit www.RapidAI.com.